Francisco Leon - 29 Dec 2022 Form 4 Insider Report for Provention Bio, Inc.

Role
Chief Scientific Officer
Signature
/s/ Thierry Chauche, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
29 Dec 2022
Net transactions value
-$1,451,101
Form type
4
Filing time
30 Dec 2022, 15:01:29 UTC
Previous filing
29 Dec 2022
Next filing
11 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRVB Common Stock Options Exercise $467,500 +187,000 +12% $2.50* 1,760,000 29 Dec 2022 Direct
transaction PRVB Common Stock Sale $1,918,601 -187,000 -11% $10.26 1,573,000 29 Dec 2022 Direct F1
holding PRVB Common Stock 1,000,000 29 Dec 2022 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRVB Stock Option (right to buy) Options Exercise $0 -187,000 -35% $0.000000 342,103 29 Dec 2022 Common Stock 187,000 $2.50 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.47 per share, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
F2 The option is fully vested.